SBG $8.84 0%
SPEH.L $5.02 0.440529%
DEVO.L $30.00 3.4483%
INFO $108.61 0%
O9A.SI $1.34 0%
VPN.L $11.07 -0.5389%
CETX $9.57 -12.0404%
OBEL.BR $14.50 -1.6282%
GIMB.BR $46.90 0.4283%
IDHQ $26.74 -0.3492%
8086.HK $0.65 0%
GNMA $44.31 -0.6279%
GTHX $2.70 -3.2258%
OVF $23.10 -0.4117%
AURC $10.17 -0.1953%
TPC $5.44 -2.4237%
IX.L $13.75 0%
HBAN $9.18 -1.1315%
LCY $12.17 0%
NESF.L $102.20 -5.1948%
DSGR $47.13 0.2766%
GGOV.PA $46.99 -0.1551%
THCAU $10.57 0%
EFC $12.19 -0.4493%
BSMQ $23.61 -0.1687%
DBC $22.68 -0.7659%
SCHY $24.12 -0.4129%
ABC $170.12 -0.7729%
CXDO $1.38 -5.4795%
GLMD $0.33 -11.2104%
AGE $0.57 -0.5063%
ESDG.L $5 360.50 0.1308%
ZETA $8.12 -2.111%
SPI.L $239.50 0%
JEQ $5.57 0.7631%
CASN4.SA $10.00 0%
WEGE3.SA $38.90 -1.0682%
RSSS $2.06 -1.7762%
SGEN $198.92 -0.2932%
IVW $64.48 -0.6702%
8048.HK $0.03 -17.6471%
FHLC $62.65 -0.6027%
ACBAU $10.54 -0.7533%
SAA.L $170.00 -0.2933%
PBP $21.54 -0.2085%
DPRO $0.92 -2.0964%
SCNY.L $33.78 0%
GAST $22.02 0%
EMBC $31.14 7.6763%
PTE $0.40 -2.439%
MFEX.L $46.81 -5.01243%
SECO $0.92 -7.61%
ASCL.L $239.20 -0.9934%
IEFS.L $676.90 0.148%
0042.HK $0.31 -1.5873%
8245.HK $0.19 -6.0606%
MORT $10.34 -0.8157%
0898.HK $1.00 0%
0QFK.L $0.61 -5%
VPU $149.21 0.1551%
EEMU.PA $13.00 0.6193%
TX $37.30 0.1342%
APTV $92.21 -2.206%
GEN.L $296.00 -1.4975%
LEGAW $0.01 0%
0484.HK $0.90 1.1236%
TBX $27.79 0.4119%
STG.L $47.00 -10.4762%
BRD $10.42 0%
DEI $10.80 -3.7879%
8491.HK $0.69 1.4706%
ARTE.PA $21.60 -0.9174%
SPPP $12.79 -2.6636%
VBNK $6.60 0.9159%
ALM.L $13.85 0%
IIF $20.13 -0.1677%
RICO $13.36 0%
SLDPW $0.30 -12.3006%
8406.HK $0.17 0%
AIA.NZ $8.78 -0.2273%
1599.HK $2.57 -3.3835%
0QGJ.L $1.63 -2.9762%
NFYS $10.25 -0.2918%
8042.HK $0.09 0%
MSB $20.38 -2.4684%
TMCI $25.21 -2.5135%
0P0000TKZM.L $25 310.40 0.2571%
XLI $97.84 -0.5843%
JGGI.L $455.50 0.1099%
FNCB $5.67 -2.4096%
CREC $10.49 0%
MONC.PA $7 250.00 0%
VRIG $24.91 -0.0405%
VEN2.L $90.50 0%
1685.HK $0.27 -3.6364%
IEFM.L $804.50 0.3618%
SPKE $11.37 0%
THC $69.25 -1.2126%
WINN $16.52 -0.8076%
PWOD $22.54 -1.6579%
Eng
Логотип
Eng
Лого

Advicenne S.A. ADVIC.PA

$6.50

На 18:01, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    0.00000000

  • week52high

    14.30

  • week52low

    3.73

  • Revenue

    1999166

  • P/E TTM

    -4

  • Beta

    1.43189000

  • EPS

    -1.77100000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    07 мая 2023 г. в 03:01

Описание компании

Advicenne S.A. develops therapeutics for the treatment of rare kidney diseases. Its lead product candidate is ADV7103 for the treatment of distal renal tubular acidosis in children and adults, as well as for the treatment of cystinuria, an inherited renal tubulopathy. The company also provides ADV6209, an oral liquid solution for children to reduce anxiety and to improve their immobility. Advicenne S.A. was founded in 2007 and is based in Paris, France.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек